A groundbreaking study has provided new insights into the synergistic effects of psilocybin and meditation on brain function and subjective...
A new study published in Nature shows that MDMA can reduce difficult experiences with other psychedelics. The post New Study Shows Candy-Flipping Can Reduce...
Investing in biotech stocks is not for the meek. Losses can be very large and occur very quickly. In fact, I’ve uncovered seven of the top...
Andy Roberts' biography of the iconic Smiles recreates a period when the UK was awash in LSD. The post Gratefully Remembering Microdot LSD in the Seventies...
Preliminary DMT therapy data will guide the decision to initiate a phase 2 trial in the U.S. in early 2024. The post Cybin Lands Key U.S....
Cannabis stocks may be some of the most controversial investing ideas. Yet, they could also become some of the most profitable.That reality may happen...
The Massachusetts attorney general has recently given the green light to two 2024 ballot initiatives aimed at legalizing psychedelics for medical use....
Reset Pharma is specifically honing in on the plight of cancer patients. The post Reset Pharma Licenses Filament Drug to Combat Demoralization in Cancer...
AWAKN-P001 Is a N-methyl-D-aspartate Receptor-Modulating Drug Used in Combination with Psycho-Social Support for The Treatment of Severe Alcohol Use Disorder...
Harm reduction and integration for people choosing to use psychedelics is important for both safety and maximization of benefits. Simply put, psychedelic...
Will PharmaTher be the next company to get a psychedelic medicine to market? The post PharmaTher Submits New Drug Application to the FDA appeared first...
A deeper look at some of the ethical concerns in the psychedelic medicine space and how to best address them. The post Ethical Concerns in Psychedelic...
Further conservation measures are required to protect Vietnamese reptiles, such as the psychedelic rock gecko (Cnemaspis psychedelica), from habitat loss...
Finding stocks with high potential for remarkable growth can be thrilling and rewarding. As the stock market fluctuates, investors constantly look for...
The newly granted U.S. patent covers deuterated 5-methoxy-dimethyltryptamine (5-MeO-DMT) analogs. The post Cybin Granted U.S. Patent for 5-MeO-DMT appeared...
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety Psychedelics biotech Cybin (NYSE: CYBN) and UK-based Small...